B. Bilo and F. Bonifazi, Epidemiology of insect-venom anaphylaxis, Current Opinion in Allergy and Clinical Immunology, vol.8, issue.4
DOI : 10.1097/ACI.0b013e32830638c5

M. Haftenberger, D. Laussmann, U. Ellert, M. Kalcklosch, U. Langen et al., [Prevalence of sensitisation to aeraoallergens and food allergens: results of the 653, p.652

U. Langen, R. Schmitz, and H. Steppuhn, Prevalence of allergic diseases in Germany: 656 results of the German Health Interview and Examination Survey for Adults, p.657

J. Bousquet, J. Anto, C. Bachert, P. Bousquet, P. Colombo et al., Factors 659 responsible for differences between asymptomatic subjects and patients presenting an 660

D. Golden, D. Marsh, A. Kagey-sobotka, L. Freidhoff, M. Szklo et al., IgE sensitization to allergens A GA2LEN project, et 662 al. Epidemiology of insect venom sensitivity, pp.671-80, 1989.

N. Nicolaou, M. Poorafshar, C. Murray, A. Simpson, H. Winell et al., Allergy or tolerance in children sensitized to peanut: Prevalence and differentiation using component-resolved diagnostics, Journal of Allergy and Clinical Immunology, vol.125, issue.1, pp.191-198, 2010.
DOI : 10.1016/j.jaci.2009.10.008

T. Schafer, B. Przybilla, P. Smith, A. Kagey-sobotka, E. Bleecker et al., IgE antibodies to Hymenoptera venoms in the serum are 667 common in the general population and are related to indications of atopy Physiologic manifestations of human anaphylaxis, Allergy J Clin Invest, vol.668, issue.719, pp.372-71072, 1980.

I. Lepow, K. Willms-kretschmer, R. Patrick, and F. Rosen, Gross and ultrastructural 723 observations on lesions produced by intradermal injection of human C3a in man, Am J, p.724

K. Wuepper, V. Bokisch, H. Muller-eberhard, and R. Stoughton, Cutaneous responses 726 to human C 3 anaphylatoxin in man, Clin Exp Immunol, vol.11, issue.727, pp.13-20, 1972.

K. Yancey, C. Hammer, L. Harvath, L. Renfer, M. Frank et al., Studies of 728 human C5a as a mediator of inflammation in normal human skin, J Clin Invest, vol.729, issue.730, pp.486-95, 1985.

J. Gorski, T. Hugli, and H. Muller-eberhard, C4a: the third anaphylatoxin of the human complement system., Proceedings of the National Academy of Sciences, vol.76, issue.10, pp.5299-302, 1979.
DOI : 10.1073/pnas.76.10.5299

D. Voehringer, Protective and pathological roles of mast cells and basophils, Nature Reviews Immunology, vol.46, issue.5, p.733
DOI : 10.1002/dvg.20378

J. Kalesnikoff and S. Galli, New developments in mast cell biology, Nature Immunology, vol.179, issue.11, pp.1215-1238, 2008.
DOI : 10.1038/nature07204

J. Abramson and I. Pecht, Regulation of the mast cell response to the type 1 Fc? receptor, Immunological Reviews, vol.168, issue.1, pp.231-54, 2007.
DOI : 10.4049/jimmunol.168.5.2087

L. Reber and N. Frossard, Targeting mast cells in inflammatory diseases, Pharmacology & Therapeutics, vol.142, issue.3, pp.416-451, 2014.
DOI : 10.1016/j.pharmthera.2014.01.004

H. Turner and J. Kinet, Signalling through the high-affinity IgE receptor Fc epsilonRI

J. Rivera, N. Fierro, A. Olivera, and R. Suzuki, Chapter 3 New Insights on Mast Cell Activation via the High Affinity Receptor for IgE, Adv Immunol, vol.98, issue.744, pp.85-120, 2008.
DOI : 10.1016/S0065-2776(08)00403-3

J. Schroeder, Basophils: emerging roles in the pathogenesis of allergic disease, Immunological Reviews, vol.121, issue.Suppl, p.745
DOI : 10.1016/j.jaci.2007.09.049

L. Alcaniz, A. Vega, P. Chacon, E. Bekay, R. Ventura et al., Histamine production by human neutrophils, The FASEB Journal, vol.27, issue.7, pp.2902-2912, 2013.
DOI : 10.1096/fj.12-223867

X. Xu, D. Zhang, H. Zhang, P. Wolters, N. Killeen et al., Neutrophil 749 histamine contributes to inflammation in mycoplasma pneumonia, J Exp Med, vol.750, issue.751, pp.2907-2924, 2006.

L. Schwartz, Diagnostic Value of Tryptase in Anaphylaxis and Mastocytosis, Immunology and Allergy Clinics of North America, vol.26, issue.3
DOI : 10.1016/j.iac.2006.05.010

L. Schwartz, D. Metcalfe, J. Miller, H. Earl, and T. Sullivan, Tryptase levels as an 754 indicator of mast-cell activation in systemic anaphylaxis and mastocytosis, N Engl J, p.755

P. Vadas, B. Perelman, and G. Liss, Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis, Journal of Allergy and Clinical Immunology, vol.131, issue.1, pp.144-153, 2013.
DOI : 10.1016/j.jaci.2012.08.016

P. Valent, C. Akin, K. Hartmann, G. Nilsson, A. Reiter et al., Advances in 766 the Classification and Treatment of Mastocytosis: Current Status and Outlook toward 767 the Future, Cancer Res, 2017.

K. Brockow, C. Jofer, H. Behrendt, and J. Ring, Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients, Allergy, vol.17, issue.1 part 1, pp.226-258, 2008.
DOI : 10.1001/archderm.1962.01590080087011

I. Alvarez-twose, S. Vano-galvan, L. Sanchez-munoz, J. Morgado, and A. Matito, Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis, Allergy, vol.106, issue.6, pp.813-834, 2012.
DOI : 10.1016/j.anai.2010.12.015

M. Sawaguchi, S. Tanaka, Y. Nakatani, Y. Harada, K. Mukai et al., Role of Mast Cells and Basophils in IgE Responses and in Allergic Airway Hyperresponsiveness, The Journal of Immunology, vol.188, issue.4, pp.1809-1827, 2012.
DOI : 10.4049/jimmunol.1101746

K. Arias, D. Chu, K. Flader, F. Botelho, T. Walker et al., Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice, Journal of Allergy and Clinical Immunology, vol.127, issue.6, pp.1552-61, 2011.
DOI : 10.1016/j.jaci.2011.03.044

L. Reber, T. Marichal, K. Mukai, Y. Kita, S. Tokuoka et al., Selective 788 ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice, p.789

J. Sun, K. Arias, D. Alvarez, R. Fattouh, T. Walker et al., Impact of CD40 794 ligand, B cells, and mast cells in peanut-induced anaphylactic responses Nonredundant roles of 797 basophils in immunity, 798 95. Bruhns P, Jonsson F. Mouse and human FcR effector functions, pp.6696-70345, 2007.

S. Jones, L. Pons, J. Roberts, A. Scurlock, T. Perry et al., Clinical 801 efficacy and immune regulation with peanut oral immunotherapy, J Allergy Clin, vol.802
DOI : 10.1016/j.jaci.2009.05.022
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725434/pdf

A. Santos, D. Toit, G. Douiri, A. Radulovic, S. Stephens et al., Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut, Journal of Allergy and Clinical Immunology, vol.135, issue.1, pp.179-86, 2015.
DOI : 10.1016/j.jaci.2014.09.001

M. Guilliams, P. Bruhns, Y. Saeys, H. Hammad, and B. Lambrecht, The function of 813

S. Bohlson, O. Conner, S. Hulsebus, H. Ho, M. Fraser et al., Complement, c1q, and 816 c1q-related molecules regulate macrophage polarization Pathways of anaphylaxis in 818 the mouse, Front Immunol J Allergy Clin Immunol, vol.5, issue.109, pp.402658-68, 2002.

F. Jonsson, D. Mancardi, M. Albanesi, and P. Bruhns, Neutrophils in local and systemic 823 antibody-dependent inflammatory and anaphylactic reactions, J Leukoc Biol, vol.824, issue.94, pp.643-56, 2013.

A. Gounni, B. Lamkhioued, L. Koussih, C. Ra, P. Renzi et al., Human neutrophils express the high-affinity receptor for immunoglobulin E (FcvarepsilonRI): role in asthma, The FASEB Journal, vol.15, issue.6, pp.940-949, 2001.
DOI : 10.1096/fj.00-0378com

A. Francis, E. Bosio, S. Stone, D. Fatovich, G. Arendts et al., Neutrophil 829 activation during acute human anaphylaxis: analysis of MPO and sCD62L, Clin Exp, p.830

S. Klebanoff, Myeloperoxidase: friend and foe, Journal of Leukocyte Biology, vol.274, issue.Suppl. 3, pp.598-625, 2005.
DOI : 10.1074/jbc.274.49.34621

A. Kasperska-zajac and B. Rogala, Platelet function in anaphylaxis, J Investig Allergol, vol.833

M. Joseph, A. Gounni, J. Kusnierz, H. Vorng, M. Sarfati et al., Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors, European Journal of Immunology, vol.20, issue.9, pp.2212-2220, 1997.
DOI : 10.1164/ajrccm/142.3.587

S. Hasegawa, R. Pawankar, K. Suzuki, T. Nakahata, S. Furukawa et al., 838 Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its' intracellular expression in human megakaryocytes, Blood, vol.840, issue.93, pp.2543-51, 1999.

A. Capron, M. Joseph, J. Ameisen, M. Capron, V. Pancre et al., Platelets as 842 effectors in immune and hypersensitivity reactions, Int Arch Allergy Appl Immunol, vol.843, issue.82, pp.307-319, 1987.

A. Rahman, B. Hartmann, H. Sampson, and M. Berin, Assessing basophil activation by using flow cytometry and mass cytometry in blood 846 stored 24 hours before analysis Mass cytometry 848 profiling the response of basophils and the complete peripheral blood compartment to 849 peanut, J Allergy Clin Immunol J Allergy Clin Immunol, vol.139, issue.138, pp.889-991741, 2016.

M. Kaliner, R. Sigler, R. Summers, and J. Shelhamer, Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responses, Journal of Allergy and Clinical Immunology, vol.68, issue.5, pp.365-71, 1981.
DOI : 10.1016/0091-6749(81)90134-2

C. Vigorito, P. Russo, G. Picotti, M. Chiariello, S. Poto et al., Cardiovascular Effects of Histamine Infusion in Man, Journal of Cardiovascular Pharmacology, vol.5, issue.4, pp.531-538, 1983.
DOI : 10.1097/00005344-198307000-00004

D. Macglashan and J. , Histamine, Journal of Allergy and Clinical Immunology, vol.112, issue.4, pp.53-62, 2003.
DOI : 10.1016/S0091-6749(03)01877-3

A. Sheikh, T. Broek, V. Brown, S. Simons, and F. , -antihistamines for the treatment of anaphylaxis: Cochrane systematic review, Allergy, vol.118, issue.8, pp.830-837, 2007.
DOI : 10.1016/j.jaci.2003.10.053

P. Gill, N. Jindal, A. Jagdis, and P. Vadas, Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis, Journal of Allergy and Clinical Immunology, vol.135, issue.6, pp.1424-1456, 2015.
DOI : 10.1016/j.jaci.2015.04.019

M. Triggiani, R. Schleimer, J. Warner, and F. Chilton, Differential synthesis of 1-acyl- 867 2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human 868 inflammatory cells, J Immunol, vol.147, pp.660-666, 1991.

C. Archer, C. Page, W. Paul, J. Morley, and D. Macdonald, Inflammatory 872 characteristics of platelet activating factor (PAF-acether) in human skin, Br J, vol.873

C. Lai, S. Ollier, C. Lau, and S. Holgate, Effect of azelastine and ketotifen on the 875 bronchial and skin responses to platelet-activating factor in humans, Clin Exp Allergy, vol.876, issue.21, pp.489-96, 1991.

L. Juhlin and I. Pihl-lundin, Effects of antihistamines on cutaneous reactions and influx of 878 eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in 879 patients with chronic urticaria and healthy subjects, Acta Derm Venereol, vol.880, issue.72, pp.197-200, 1992.

N. Kajiwara, T. Sasaki, P. Bradding, G. Cruse, H. Sagara et al., Activation of 882 human mast cells through the platelet-activating factor receptor, J Allergy Clin, vol.883

M. Church, Platelet-activating factor (PAF) induces wheal and flare skin 886 reactions independent of mast cell degranulation, Allergy, vol.68, pp.256-264, 2013.

P. Vadas, M. Gold, B. Perelman, G. Liss, G. Lack et al., Platelet-Activating Factor, PAF Acetylhydrolase, and Severe Anaphylaxis, New England Journal of Medicine, vol.358, issue.1, pp.28-35, 2008.
DOI : 10.1056/NEJMoa070030

K. Austen, The cysteinyl leukotrienes: where do they come from? What are they?, p.890
DOI : 10.1038/ni0208-113

M. Peters-golden, M. Gleason, and A. Togias, Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.94, issue.6, pp.689-703, 2006.
DOI : 10.1067/mai.2000.106040

N. Higashi, H. Mita, E. Ono, Y. Fukutomi, H. Yamaguchi et al., Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers, Journal of Allergy and Clinical Immunology, vol.125, issue.5, pp.1084-91, 2010.
DOI : 10.1016/j.jaci.2009.12.977

E. Ono, M. Taniguchi, H. Mita, Y. Fukutomi, N. Higashi et al., Increased 897 production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis, p.898

C. Denzlinger, C. Haberl, and W. Wilmanns, Cysteinyl Leukotriene Production in Anaphylactic Reactions, International Archives of Allergy and Immunology, vol.108, issue.2, pp.158-64, 1995.
DOI : 10.1159/000237133

N. Soter, R. Lewis, E. Corey, and K. Austen, Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin, Journal of Investigative Dermatology, vol.80, issue.2, pp.115-124, 1983.
DOI : 10.1111/1523-1747.ep12531738

Y. Kanaoka, A. Maekawa, J. Penrose, K. Austen, B. Lam et al., Synthase, Journal of Biological Chemistry, vol.78, issue.25, pp.22608-90620820, 2001.
DOI : 10.1016/0014-2999(92)90720-O

M. Lessof, L. Youlten, D. Heavey, D. Kemeny, and C. Dollery, Local mediator release in bee venom anaphylaxis, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.129, issue.2, pp.231-233, 1989.
DOI : 10.1016/0090-6980(84)90033-9

C. Hack, J. Poortman, and Y. Vivie-kipp, affinity IgE receptors, and CCL2 in human anaphylaxis, J Allergy Clin Immunol, vol.914

J. Zwan, Insect-sting challenge in 138 patients: relation between clinical severity of 917 anaphylaxis and mast cell activation, J Allergy Clin Immunol, vol.90, pp.110-118, 1992.

R. Pumphrey, Fatal anaphylaxis in the UK, Novartis Found Symp, vol.925, issue.257, pp.116-144, 1992.

P. Lieberman, Biphasic anaphylactic reactions, Annals of Allergy, Asthma & Immunology, vol.95, issue.3, pp.217-243, 2005.
DOI : 10.1016/S1081-1206(10)61217-3

J. Kalesnikoff and S. Galli, Anaphylaxis: Mechanisms of Mast Cell Activation, Chem Immunol Allergy Basel: Karger, vol.95, pp.45-66, 2010.
DOI : 10.1159/000315937

D. Mancardi, B. Iannascoli, S. Hoos, P. England, M. Daeron et al., Fc??RIV is a mouse IgE receptor that resembles macrophage Fc??RI in humans and promotes IgE-induced lung inflammation, Journal of Clinical Investigation, vol.118, issue.11, pp.3738-50, 2008.
DOI : 10.1172/JCI36452DS1

S. Mckenzie, S. Taylor, P. Malladi, H. Yuhan, D. Cassel et al., The role of 950 the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a 951 transgenic mouse model, J Immunol, vol.162, pp.4311-4319, 1999.

O. Burton, A. Stranks, J. Tamayo, K. Koleoglou, L. Schwartz et al., A 959 humanized mouse model of anaphylactic peanut allergy, J Allergy Clin Immunol, vol.960, issue.139, pp.314-336, 2017.

A. Apter, H. Schelleman, A. Walker, K. Addya, and T. Rebbeck, Clinical and genetic risk factors of self-reported penicillin allergy, Journal of Allergy and Clinical Immunology, vol.122, issue.1, pp.152-160, 2008.
DOI : 10.1016/j.jaci.2008.03.037

R. Brown, R. Hamilton, M. Mintz, A. Jedlicka, A. Scott et al., Genetic 982 predisposition to latex allergy: role of interleukin 13 and interleukin 18, p.983

K. Karasawa, A. Harada, N. Satoh, K. Inoue, and M. Setaka, Plasma platelet activating factor-acetylhydrolase (PAF-AH), Progress in Lipid Research, vol.42, issue.2, pp.93-114, 2003.
DOI : 10.1016/S0163-7827(02)00049-8

C. Summers, R. Pumphrey, C. Woods, G. Mcdowell, and P. Pemberton, Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center, Journal of Allergy and Clinical Immunology, vol.121, issue.3, pp.632-640, 2008.
DOI : 10.1016/j.jaci.2007.12.003

V. Hox, O. Connell, M. Lyons, J. Sackstein, P. Dimaggio et al., Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis, Journal of Allergy and Clinical Immunology, vol.138, issue.1, pp.187-99, 2016.
DOI : 10.1016/j.jaci.2015.11.024

L. Webb and P. Lieberman, Anaphylaxis: a review of 601 cases, Annals of Allergy, Asthma & Immunology, vol.97, issue.1, 1011.
DOI : 10.1016/S1081-1206(10)61367-1

M. Worm, G. Edenharter, F. Ruëff, K. Scherer, C. Pföhler et al., Symptom profile and risk factors of anaphylaxis in Central Europe, Allergy, vol.153, issue.Suppl 1, pp.691-699, 2012.
DOI : 10.1111/j.1365-2249.2008.03714.x

V. Hox, A. Desai, G. Bandara, A. Gilfillan, D. Metcalfe et al., Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production, Journal of Allergy and Clinical Immunology, vol.135, issue.3, pp.729-765, 1017.
DOI : 10.1016/j.jaci.2014.11.003

W. Francuzik, M. Nassiri, M. Babina, and M. Worm, Impact of sex on anaphylaxis 1019 severity?data from the Anaphylaxis Registry, J Allergy Clin Immunol, vol.1020, issue.136, pp.1425-1431, 2015.

P. Piper and H. Collier, Release of Catecholamines in the Guinea-pig by Substances involved in Anaphylaxis, Nature, vol.179, issue.5078, pp.838-878, 1023.
DOI : 10.1016/S0140-6736(64)92617-0

M. Khodoun, R. Strait, T. Orekov, S. Hogan, H. Karasuyama et al., Peanuts 1027 can contribute to anaphylactic shock by activating complement, J Allergy Clin, 1028.
DOI : 10.1016/j.jaci.2008.11.004
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670761/pdf

W. Zhang, T. Shibamoto, Y. Kurata, and H. Kohno, Effects of ??-adrenoceptor antagonists on anaphylactic hypotension in conscious rats, European Journal of Pharmacology, vol.650, issue.1, pp.303-311, 2011.
DOI : 10.1016/j.ejphar.2010.10.015

L. Awai and Y. Mekori, Insect sting anaphylaxis and beta-adrenergic blockade: a 1032 relative contraindication, Ann Allergy, vol.53, pp.48-57, 1984.

D. Lang, Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers. Drug 1037, Safety, vol.12, pp.299-304, 1995.

M. Nassiri, M. Babina, S. Dölle, G. Edenharter, F. Ruëff et al., Ramipril and metoprolol intake aggravate human and murine anaphylaxis: Evidence for direct mast cell priming, Journal of Allergy and Clinical Immunology, vol.135, issue.2, pp.491-500, 2015.
DOI : 10.1016/j.jaci.2014.09.004

M. Li, K. Liu, J. Michalicek, J. Angus, J. Hunt et al., Involvement of chymase-mediated angiotensin II generation in blood pressure regulation, Journal of Clinical Investigation, vol.114, issue.1, pp.112-132, 1047.
DOI : 10.1172/JCI200420805

T. Nakamura, Y. F. Yamada, R. Fujii, W. Hamabata, T. Lee et al., Mast cell? 1049 derived prostaglandin D2 attenuates anaphylactic reactions in mice, J Allergy Clin, 1050.
DOI : 10.1016/j.jaci.2017.02.030

T. Marichal, P. Starkl, L. Reber, J. Kalesnikoff, H. Oettgen et al., A beneficial 1052 role for immunoglobulin E in host defense against honeybee venom, Immunity, vol.39188, pp.963-75, 1053.

N. Palm, R. Rosenstein, S. Yu, D. Schenten, E. Florsheim et al., Bee Venom Phospholipase A2 Induces a Primary Type 2 Response that Is Dependent on the Receptor ST2 and Confers Protective Immunity, Immunity, vol.39, issue.5, pp.976-85, 2013.
DOI : 10.1016/j.immuni.2013.10.006

P. Starkl, T. Marichal, N. Gaudenzio, L. Reber, R. Sibilano et al., IgE antibodies, Fc??RI??, and IgE-mediated local anaphylaxis can limit snake venom toxicity, Journal of Allergy and Clinical Immunology, vol.137, issue.1, pp.246-57, 2016.
DOI : 10.1016/j.jaci.2015.08.005
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715494/pdf

M. Akahoshi, C. Song, A. Piliponsky, M. Metz, A. Guzzetta et al., Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice, Journal of Clinical Investigation, vol.121, issue.10, pp.4180-91, 2011.
DOI : 10.1172/JCI46139DS1

M. Metz, A. Piliponsky, C. Chen, V. Lammel, M. Abrink et al., Mast Cells Can Enhance Resistance to Snake and Honeybee Venoms, Science, vol.313, issue.5786, pp.526-556, 2006.
DOI : 10.1126/science.1128877

H. Oettgen, T. Martin, A. Wynshaw-boris, C. Deng, J. Drazen et al., Active anaphylaxis in IgE-deficient mice, Nature, vol.370, issue.6488, pp.367-70, 1994.
DOI : 10.1038/370367a0

A. Cheifetz, M. Smedley, S. Martin, M. Reiter, G. Leone et al., The incidence 1076 and management of infusion reactions to infliximab: a large center experience, Am J, p.1077

K. Price and R. Hamilton, Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy, Allergy and Asthma Proceedings, vol.28, issue.3, pp.313-1083, 2007.
DOI : 10.2500/aap.2007.28.3003

T. Kodama, H. Sekine, M. Takahashi, D. Iwaki, T. Machida et al., Role of complement in a murine model of peanut-induced anaphylaxis, Immunobiology, vol.218, issue.6, pp.844-50, 1086.
DOI : 10.1016/j.imbio.2012.10.003

B. Schafer, A. Piliponsky, T. Oka, C. Song, N. Gerard et al., Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice, Journal of Allergy and Clinical Immunology, vol.131, issue.2, pp.541-549, 2013.
DOI : 10.1016/j.jaci.2012.05.009

D. Jiao, Y. Liu, X. Lu, B. Liu, Q. Pan et al., Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice, Cellular Immunology, vol.289, issue.1-2, pp.97-105, 1093.
DOI : 10.1016/j.cellimm.2014.03.018

J. Jenseniuis, Investigations on the involvement of the lectin pathway of 1096 complement activation in anaphylaxis, Int Arch Allergy Immunol, vol.141, pp.11-23, 2006.

T. Takeishi, T. Martin, I. Katona, F. Finkelman, and S. Galli, Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses., Journal of Clinical Investigation, vol.88, issue.2, pp.598-608, 1991.
DOI : 10.1172/JCI115344

Y. Makabe-kobayashi, Y. Hori, T. Adachi, S. Ishigaki-suzuki, Y. Kikuchi et al., al. The control effect of histamine on body temperature and respiratory function in 1107

J. Wechsler, H. Schroeder, A. Byrne, K. Chien, and P. Bryce, Anaphylactic responses to histamine in mice utilize both histamine receptors 1 and 2, Allergy, vol.529, issue.6 Suppl, pp.1338-1110, 2013.
DOI : 10.1016/j.ejphar.2005.10.060

K. Arias, M. Baig, M. Colangelo, D. Chu, T. Walker et al., Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions, Journal of Allergy and Clinical Immunology, vol.124, issue.2, pp.307-321, 2009.
DOI : 10.1016/j.jaci.2009.03.012

D. Kelefiotis and C. Vakirtzi-lemonias, In vivo responses of mouse blood cells to platelet- 1115 activating factor (PAF): role of the mediators of anaphylaxis, Agents Actions, vol.1116, issue.40, pp.150-156, 1993.

S. Ishii, T. Kuwaki, T. Nagase, K. Maki, F. Tashiro et al., Impaired Anaphylactic Responses with Intact Sensitivity to Endotoxin in Mice Lacking a Platelet-activating Factor Receptor, The Journal of Experimental Medicine, vol.64, issue.11, pp.1779-88, 1998.
DOI : 10.1161/01.RES.73.6.991